Citadel Advisors’s Actinium Pharmaceuticals ATNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$77K Buy
+55,006
New +$77K ﹤0.01% 5348
2025
Q1
Sell
-298
Closed -$375 5932
2024
Q4
$375 Buy
298
+275
+1,196% +$346 ﹤0.01% 5873
2024
Q3
$43 Sell
23
-65,454
-100% -$122K ﹤0.01% 5701
2024
Q2
$485K Sell
65,477
-42,638
-39% -$316K ﹤0.01% 3816
2024
Q1
$847K Buy
108,115
+75,707
+234% +$593K ﹤0.01% 3363
2023
Q4
$165K Sell
32,408
-36,682
-53% -$186K ﹤0.01% 4696
2023
Q3
$409K Sell
69,090
-102,980
-60% -$610K ﹤0.01% 3967
2023
Q2
$1.28M Buy
172,070
+103,136
+150% +$765K ﹤0.01% 2765
2023
Q1
$651K Sell
68,934
-52,488
-43% -$496K ﹤0.01% 3616
2022
Q4
$1.29M Buy
121,422
+80,314
+195% +$855K ﹤0.01% 2979
2022
Q3
$303K Sell
41,108
-12,360
-23% -$91.1K ﹤0.01% 4531
2022
Q2
$257K Buy
53,468
+28,798
+117% +$138K ﹤0.01% 4766
2022
Q1
$126K Buy
+24,670
New +$126K ﹤0.01% 5529
2021
Q4
Sell
-11,001
Closed -$98K 6431
2021
Q3
$98K Buy
+11,001
New +$98K ﹤0.01% 5889
2021
Q2
Hold
0
6396
2021
Q1
Sell
-46,487
Closed -$363K 6242
2020
Q4
$363K Buy
46,487
+30,527
+191% +$238K ﹤0.01% 4088
2020
Q3
$155K Sell
15,960
-5,472
-26% -$53.1K ﹤0.01% 4156
2020
Q2
$226K Buy
21,432
+19,138
+834% +$202K ﹤0.01% 3994
2020
Q1
$13K Buy
+2,294
New +$13K ﹤0.01% 4710
2019
Q4
Sell
-5,120
Closed -$35K 4607
2019
Q3
$35K Buy
+5,120
New +$35K ﹤0.01% 4418
2019
Q1
Sell
-5,384
Closed -$63K 4511
2018
Q4
$63K Buy
+5,384
New +$63K ﹤0.01% 4079
2018
Q3
Sell
-1,114
Closed -$21K 4264
2018
Q2
$21K Buy
+1,114
New +$21K ﹤0.01% 4039
2017
Q4
Sell
-1,952
Closed -$34K 3847
2017
Q3
$34K Buy
+1,952
New +$34K ﹤0.01% 3449
2017
Q2
Hold
0
3633
2016
Q4
Hold
0
3561
2016
Q3
Hold
0
3557
2016
Q2
Sell
-657
Closed -$39K 3351
2016
Q1
$39K Buy
657
+354
+117% +$21K ﹤0.01% 3041
2015
Q4
$29K Sell
303
-107
-26% -$10.2K ﹤0.01% 3540
2015
Q3
$22K Sell
410
-836
-67% -$44.9K ﹤0.01% 3713
2015
Q2
$99K Buy
+1,246
New +$99K ﹤0.01% 3265